Literature DB >> 18427719

Hyaluronan inhibits IL-1beta-stimulated collagenase production via down-regulation of phosphorylated p38 in SW-1353 human chondrosarcoma cells.

Sohel M Julovi1, Hiromu Ito, Teruko Hiramitsu, Tadashi Yasuda, Takashi Nakamura.   

Abstract

We investigated the intracellular mechanism for the inhibitory effects of hyaluronan (HA) on interleukin-1beta (IL-1beta)-stimulated collagenase-1 and -3 (matrix metalloproteinases (MMPs)-1 and -13) production in a human chondrosarcoma cell line, SW-1353. MMPs-1 and -13 were induced by IL-1beta at 2 ng/ml in SW-1353 cells for 48 h. HA of 800 kDa, which is used clinically, significantly suppressed IL-1beta-stimulated production of MMPs-1 and -13 by immunoblotting. SW-1353 cells express the standard form of CD44 (CD44H), and immunofluorescent cytochemistry demonstrated the association of HA with CD44 on SW-1353 cells. Phosphorylated p38 (Phos-p38) mitogen-activated protein kinase was stimulated in SW-1353 cells by IL-1beta but not by HA alone. SB203580, a p38 MAPK inhibitor, partially blocked the MMP-1 and -13 production stimulated by IL-1beta. 800-kDa HA suppressed IL-1beta-activated Phos-p38 in a dose-dependent manner. CD44 blocking significantly reversed the inhibitory effects of HA on IL-1beta-activated Phos-p38 production. The present study clearly suggests that HA binds CD44 and inhibits IL-1beta-induced MMP-1 and -13 expression via down-regulation of Phos-p38 in SW-1353 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427719     DOI: 10.1007/s10165-008-0067-7

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  8 in total

1.  Inflammatory effect of advanced glycation end products on human meniscal cells from osteoarthritic knees.

Authors:  Hideki Hiraiwa; Tadahiro Sakai; Hirohito Mitsuyama; Takashi Hamada; Ryuichiro Yamamoto; Takaaki Omachi; Yohei Ohno; Motoshige Nakashima; Naoki Ishiguro
Journal:  Inflamm Res       Date:  2011-08-13       Impact factor: 4.575

2.  Hyaluronan inhibits p38 mitogen-activated protein kinase via the receptors in rheumatoid arthritis chondrocytes stimulated with fibronectin fragment.

Authors:  Tadashi Yasuda
Journal:  Clin Rheumatol       Date:  2010-06-15       Impact factor: 2.980

3.  Activated protein C inhibits proliferation and tumor necrosis factor α-stimulated activation of p38, c-Jun NH2-terminal kinase (JNK) and Akt in rheumatoid synovial fibroblasts.

Authors:  Sohel M Julovi; Kaitlin Shen; Kelly Mckelvey; Nikita Minhas; Lyn March; Christopher J Jackson
Journal:  Mol Med       Date:  2013-10-24       Impact factor: 6.354

4.  A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan.

Authors:  Margaret M Smith; Amy K Russell; Antonella Schiavinato; Christopher B Little
Journal:  J Inflamm (Lond)       Date:  2013-07-27       Impact factor: 4.981

5.  Reactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells.

Authors:  Yuta Onodera; Takeshi Teramura; Toshiyuki Takehara; Kanae Shigi; Kanji Fukuda
Journal:  FEBS Open Bio       Date:  2015-06-06       Impact factor: 2.693

6.  Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac.

Authors:  Keiji Yoshioka; Tomochika Kisukeda; Ryoji Zuinen; Yosuke Yasuda; Kenji Miyamoto
Journal:  BMC Musculoskelet Disord       Date:  2018-05-22       Impact factor: 2.362

Review 7.  Current and future options for dental pulp therapy.

Authors:  Takahiko Morotomi; Ayako Washio; Chiaki Kitamura
Journal:  Jpn Dent Sci Rev       Date:  2018-09-29

8.  Interleukin-1β induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes.

Authors:  Szu-Yu Chien; Chun-Yin Huang; Chun-Hao Tsai; Shih-Wei Wang; Yu-Min Lin; Chih-Hsin Tang
Journal:  Clin Sci (Lond)       Date:  2016-01-25       Impact factor: 6.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.